In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies

Since the first approval of monoclonal antibodies by the United States Food and Drug Administration (FDA) in 1986, therapeutic antibodies have become one of the predominant classes of drugs in oncology and immunology. Despite their natural function in contributing to antiviral immunity, antibodies a...

Full description

Saved in:
Bibliographic Details
Main Authors: Silvere Pagant, Rachel A. Liberatore
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
Online Access:https://doaj.org/article/6f6f391b209048c09e5cae17cdd445d3
Tags: Add Tag
No Tags, Be the first to tag this record!